| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cyteir Therapeutics, Inc. | Director | Common Stock | 2.44M | $4.13M | $1.69 | Feb 14, 2024 | Indirect |
| Cyteir Therapeutics, Inc. | Director | Common Stock | 14.2K | $23.9K | $1.69 | Feb 14, 2024 | Direct |
| Calithera Biosciences, Inc. | Director | Stock Option (Right to Buy) | 20K | Jun 11, 2021 | Direct | ||
| Cyteir Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | Feb 14, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CYT | Cyteir Therapeutics, Inc. | Feb 14, 2024 | 2 | $23.9K | 4 | Feb 16, 2024 | Director |
| CYT | Cyteir Therapeutics, Inc. | Feb 3, 2023 | 1 | $0 | 4 | Feb 7, 2023 | Director |
| CYT | Cyteir Therapeutics, Inc. | Feb 22, 2022 | 1 | $0 | 4 | Feb 24, 2022 | Director |
| CYT | Cyteir Therapeutics, Inc. | Jun 22, 2021 | 3 | $0 | 4 | Jun 24, 2021 | Director |
| CYT | Cyteir Therapeutics, Inc. | Jun 17, 2021 | 0 | $0 | 3 | Jun 17, 2021 | Director |
| CALA | Calithera Biosciences, Inc. | Jun 11, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |